170480 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants; Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3 CD4
CD127 EXPRESSION INVERSELY CORRELATES WITH FOXP3 AND SUPPRESSIVE FUNCTION OF CD4+ TREGS
#2COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS AND ANTI-PD-1 ANTIBODIES
#3METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY
#4MICROIMPRINTING OF ANTIBODIES AND BIOMOLECULES FOR CELL PHENOTYPING AND ACTIVATION
#5LIQUID BIOPSY FOR DIAGNOSIS OF EARLY OSTEOARTHRITIS
#6METHODS FOR PREDICTING THE USEFULNESS OF DISEASE SPECIFIC AMINO ACID MODIFICATIONS FOR IMMUNOTHERAPY
#7REGULATORY T CELL STABILITY ASSAY
#8METHODS FOR PRODUCING GENETICALLY ENGINEERED CELL COMPOSITIONS AND RELATED COMPOSITIONS
#9DEVICES, SOLUTIONS AND METHODS FOR SAMPLE COLLECTION RELATED APPLICATIONS, ANALYSIS AND DIAGNOSIS
#10METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY
#11METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY
#12METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY
#13Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
#14PRODUCTS AND USES THEREOF FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO CANCER IMMUNOTHERAPY AND FOR SELECTING OPTIMIZED THERAPY
#15METHODS OF ASSESSING OR MONITORING A RESPONSE TO A CELL THERAPY
#16TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
#17NOVEL SINGLE DOMAIN ANTIGEN BINDING MOLECULES AND THEIR USES
#18HEMATOPOIETIC CELL PHENOTYPING USING CIRCULATING CELL-FREE MARKERS
#19METHODS OF DETERMINING POTENCY OF A THERAPEUTIC CELL COMPOSITION
#20TOLEROGENIC SYNTHETIC NANOCARRIERS
#21Methods for producing genetically engineered cell compositions and related compositions
#22Reagent composition for detection of non-hematopoietic tumor and use thereof
#23METHODS AND COMPOSITIONS FOR IN SITU IMMUNE PROFILING OF HEART TRANSPLANT BIOPSIES
#24IMMUNOLOGICAL BIOMARKER FOR PREDICTING CLINICAL EFFECT OF CANCER IMMUNOTHERAPY
#25TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE IMMUNE RESPONSES TO THERAPEUTIC PROTEINS
#26TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
#27TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ALLERGY THERAPY
#28METHOD FOR LABELING INTRACELLULAR AND EXTRACELLULAR TARGETS OF LEUKOCYTES
#29CD127 EXPRESSION INVERSELY CORRELATES WITH FOXP3 AND SUPPRESSIVE FUNCTION OF CD4+ TREGS
#30BREAST CANCER BIOMARKERS AND METHODS OF USE
#31Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
#32Flow Cytometry System and Methods for the Diagnosis of Infectious Disease
#33STRATIFYING RISK OF MALIGNANCY IN INDETERMINATE THYROID NODULES AND IMMUNO-GENOMIC MARKERS FOR EARLY DETECTION OF THYROID CANCER
#34CYTOMETRIC ASSAYS
#35METHODS FOR PROVIDING POLYMERIC SYNTHETIC NANOCARRIERS FOR GENERATING ANTIGEN-SPECIFIC TOLERANCE IMMUNE RESPONSES
#36Postural Orthostatic Tachycardia Syndrome and CRTH2
#37METHODS OF DETERMINING PATIENT POPULATIONS AMENABLE TO IMMUNOMODULATORY TREATMENT OF CANCER
#38Immunological biomarker for predicting clinical effect of cancer
#39PERIPHERAL BLOOD BIOMARKER FOR EVALUATING ANTI-TUMOR IMMUNE EFFECT OF RADIATION THERAPY
#40SPATIAL MAPPING OF CELLS AND CELL TYPES IN COMPLEX TISSUES
#41AFFINITY-OLIGONUCLEOTIDE CONJUGATES AND USES THEREOF
#42Method for the evaluation of antiretroviral therapy (ART) effectiveness in HIV-1 CD4+CD89+ cellular reservoirs
#43Methods of immunotherapy
#44Methods and kits for determining tuberculosis infection status
#45IDENTIFICATION OF IMMUNOGENIC MHC CLASS II PEPTIDES FOR IMMUNE-BASED THERAPY
#46Methods of assessing or monitoring a response to a cell therapy
#47ASSAYS FOR DETECTING T CELL IMMUNE SUBSETS AND METHODS OF USE THEREOF
#48ANTIGEN-SPECIFIC HELPER T-CELL RECEPTOR GENES
#49METHODS AND KITS FOR EVALUATING CLINICAL OUTCOMES OF AUTOIMMUNE DISEASE
#50Antibodies against OX-40 and uses thereof
#51MODULATION OF SPLENOCYTES IN CELL THERAPY
#52Prediction of response to immune-modulatory therapies
#53BACTERIA CAUSING SEXUALLY-TRANSMITTED DISEASES AND IMMUNE T-CELL DETECTION
#54Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment
#55Lymphocyte biomarkers for determining the clinical response to cell therapy
#56Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
#57Agents and methods to elicit anti-tumor immune response
#58Methods for producing genetically engineered cell compositions and related compositions
#59METHODS AND KITS FOR IDENTIFYING EFFECTOR TREG CELLS
#60Method for the detection, preparation and depletion of CD4+ t lymphocytes
#61TOLEROGENIC SYNTHETIC NANOCARRIERS FOR GENERATING CD8+ REGULATORY T CELLS
#62TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS
#63Affinity-oligonucleotide conjugates and uses thereof
#64Nanofraction immune modulators, preparations and compositions including the same, and associated methods
#65EFFECTOR TYPE REGULATORY T CELL DETECTING METHOD, EFFECTOR TYPE REGULATORY T CELL ANALYZING DEVICE, EFFECTOR TYPE REGULATORY T CELL ANALYZING SYSTEM, AND NON-TRANSITORY STORAGE MEDIUM
#66Methods of Isolating Naive Regulatory T Cells
#67Method for isolating HIV reservoir cells expressing CD32a cell marker
#68Immunological biomarker for predicting clinical effect of cancer
#69FLOW CYTOMETRY ASSAY METHODS
#70METHODS AND KITS FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO IMMUNOTHERAPY
#71Method for the detection of cells associated with the latent HIV viral reservoir using membrane biomarkers
#72Antigen-specific helper T-cell receptor genes
#73Method for identifying a bacterial infection
#74TREATING PATIENTS BASED ON IMMUNE SUBTYPES
#75Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
#76Hematopoietic cell phenotyping using circulating cell-free markers
#77Single cell characterization using affinity-oligonucleotide conjugates and vessel barcoded polynucleotides
#78Methods for determining the risk of cardiovascular disease in a subject having a chronic viral infection through the measurement of lysophosphatidic acid
#79Regulatory T-cells, method for their isolation and uses
#80Cytometric assays
#81Flow cytometry system and methods for the diagnosis of infectious disease
#82Methods and kits for determining tuberculosis infection status
#83Agents and methods to elicit anti-tumor immune response
#84Modulation of splenocytes in cell therapy
#85IMMUNOLOGICAL TEST KIT FOR EVALUATING VACCINE EFFICACY AND STORAGE METHOD THEREOF
#86CD127 expression inversely correlates with FoxP3 and suppressive function of CD4 Tregs
#87Assays for detecting T cell immune subsets and methods of use thereof
#88In-vitro methods for the detection of autoimmune diseases or conditions
#89Methods and compositions for obtaining a tuberculosis assessment in a subject
#90Methods of diagnosing infection or recurrence in a subject
#91Identification of immunogenic MHC class II peptides for immune-based therapy
#92Methods and kits for labeling, detection and isolation of Foxp3 regulatory T cells, isolated population of Foxp3 regulatory T cells thus obtained and uses thereof
#93Methods of determining patient populations amenable to immunomodulatory treatment of cancer
#94Simple and affordable method for immuophenotyping using a microfluidic chip sample preparation with image cytometry
#95Devices, solutions and methods for sample collection related applications, analysis and diagnosis
#96Methods For Screening Therapeutic Compounds
#97Universal cancer peptides derived from telomerase
#98Biomarker And Therapy Intervention For Malignancy Risk Patients
#99Cell identification method
#100Measuring HIV reservoirs with optical scanning
#101Detection of an immune response
#102Antibodies against OX40 and uses thereof
#103Methods of selecting T cell receptors using affinity oligonucleotide conjugates
#104proteins
#105Methods and compositions for T cell generation and uses thereof
#106Immunopotentiator potentiating tumor immunity or infection immunity
#107Method for diagnosing fibromyalgia syndrome, and kit therefor
#108Methods of diagnosing and treating tuberculosis
#109Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
#110Virion display array for profiling functions and interactions of human membrane proteins
#111Stable nanomagnetic particle dispersions
#112Drug target site within GP120 of HIV
#113Agents and methods to elicit anti-tumor immune response
#114Blood analyzer and blood analysis method
#115Tolerogenic synthetic nanocarriers for allergy therapy
#116Tolerogenic synthetic nanocarriers
#117Methods and kits for determining tuberculosis infection status
#118Methods and kits for identifying effector Treg cells
#119Simultaneous Assay of Target and Target-Drug Binding
#120Complexes of types of MHC class II that bind to collagen type II peptides and their use on diagnosis and treatment
#121Hematopoietic cell phenotyping using circulating cell-free markers
#122Detection of an immune response
#123Detection of gluten-specific t-cells
#124METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#125METHOD FOR THE DETECTION, PREPARATION AND DEPLETION OF CD4+ T LYMPHOCYTES
#126METHODS FOR DIAGNOSIS OF CELIAC DISEASE
#127Treating patients based on immune subtypes
#128Aquaporin-4 Peptide Compositions and Methods of Use
#129Methods for stimulating antigen-specific T cell responses
#130Lymphocyte biomarkers for determining the clinical response to cell therapy
#131Immunogenic antigens from
#132Anti-lymphocyte autoantibodies as diagnostic biomarkers
#133Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
#134Method for identifying a bacterial infection
#135Antigen-specific helper T-cell receptor genes
#136IN VIVO EFFICACY OF NY-ESO-1 PLUS ADJUVANT
#137IN VITRO METHOD FOR THE DIAGNOSIS AND SURVEILLANCE OF CANCER
#138Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
#139Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
#140Peptide MHCII tetramers to detect endogenous calnexin specific CD4 T cells
#141Methods for determining the risk of acute graft versus host disease
#142Universal cancer peptides derived from telomerase
#143ISOLATION OF CELLS AND BIOLOGICAL SUBSTANCES USING BUOYANT MICROBUBBLES
#144CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ tregs
#145DETERMINATION OF EFFICIENT TIME(S) FOR CHEMOTHERAPY DELIVERY
#146Methods and kits for determining whether a patient with cirrhosis is at risk of having clinically significant portal hypertension
#147Devices and methods for determining and/or isolating circulating cancer cells
#148CANCER PROGNOSTIC ASSAYS
#149METHOD FOR DETERMINING THE IMMUNE STATUS OF A SUBJECT
#150Method for labeling intracellular and extracellular targets of leukocytes
#151Method and kit for determining-antibody sensitivity and clone cell strain
#152Simultaneous Assay of Target and Target-Drug Binding
#153METHODS AND COMPOSITIONS FOR DETECTING AND TREATING INFLAMMATORY DISEASE
#154Flow cytometry assay methods
#155Flow-through cell counting assay
#156Tolerogenic synthetic nanocarriers for inducing regulatory B cells
#157Simple and affordable method for immunophenotyping using a microfluidic chip sample preparation with image cytometry
#158System and method of verification of a prepared sample for a flow cytometer
#159NEW METHODS FOR ISOLATING TR1 CELLS
#160CELL FREE CD4 QUANTITATION AND METHODS OF USE
#161Agents for treating disease
#162Methods for diagnosis, prognosis and methods of treatment
#163TOLEROGENIC SYNTHETIC NANOCARRIERS COUPLED TO CD1D-RESTRICTED ANTIGENS AND METHODS OF USE
#164CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS
#165Tolerogenic synthetic nanocarriers for allergy therapy
#166TOLEROGENIC SYNTHETIC NANOCARRIERS FOR REGULATING INNATE IMMUNE RESPONSES
#167Tolerogenic synthetic nanocarriers
#168Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses
#169TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES
#170TOLEROGENIC SYNTHETIC NANOCARRIER COMPOSITIONS WITH TRANSPLANTABLE GRAFT ANTIGENS AND METHODS OF USE
#171Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells
#172ENV POLYPEPTIDE COMPLEXES AND METHODS OF USE
#173Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells
#174Tolerogenic synthetic nanocarriers for inducing regulatory B cells
#175Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
#176LYMPHOCYTE ANALYSIS FOR MONITORING THE PROGRESSION OF IMMUNODEFICIENCY VIRUS
#177Ki-67 ASSAY FOR PATIENT IMMUNE SYSTEM STATUS
#178IN VIVO EFFICACY OF NY-ESO-1 PLUS ADJUVANT
#179MULTI-FREQUENCY IMPEDANCE METHOD AND APPARATUS FOR DISCRIMINATING AND COUNTING PARTICLES EXPRESSING A SPECIFIC MARKER
#180METHODS AND COMPOSITIONS FOR DETECTING AND TREATING INFLAMMATORY DISEASE
#181Method of assaying an individual for immune impairment
#182Kit for identifying regulatory T cells
#183Methods of Using Labeled Ligands Having Human CD4 Specificity
#184Capturing particles
#185Modulation of splenocytes in cell therapy
#186Agents and methods to elicit anti-tumor immune response
#187Method of diagnosis and kit therefor
#188DIAGNOSTIC AND THERAPEUTIC PROTOCOLS
#189METHODS FOR PREDICTING DEVELOPMENT OF AUTO-IMMUNE DISEASES AND TREATMENT OF SAME
#190Assay for analysis of free drug in samples
#191METHODS FOR MAKING HIV VACCINES AND RELATED COMPOSITIONS
#192Cellular COPD Diagnosis
#193Methods, devices, and systems for chemiluminescence-based microfluidic cell counting
#194Method and apparatus for imaging target components in a biological sample using permanent magnets
#195System and method of verification of a prepared sample for a flow cytometer
#196Determining whether a test compound modulates PD-1 activity in activated immune cells using gene expression profiles
#197Anti-CD4 antibody
#198IMMUNODEFICIENCY SCREENING AT POINT OF CARE
#199Flow cytometry methods and immunodiagnostics with mass sensitive readout
#200METHOD FOR IDENTIFICATION OF T-LYMPHOCYTE ANTIGENS
#201METHODS FOR TREATING CACHEXIA AND LYMPHOPENIA
#202Density-based cell detection system
#203PATHOGEN BINDING
#204Hematopoietic cell phenotyping using circulating cell-free markers
#205Method for identifying regulatory T cells
#206Cell classification system
#207Method of identifying CD4+ T cell antigens
#208METHOD FOR DIAGNOSING AND MONITORING CELLULAR RESERVOIRS OF DISEASE
#209Method for detecting antigen specific or mitogen-activated T cells
#210Device and methods for detecting a target cell
#211Identification of thymically derived CD4 T cells by protein tyrosine kinase 7 expression
#212Methods for diagnosis prognosis and methods of treatment
#213DIAGNOSTIC ASSAY FOR DETECTING AND MONITORING AGE RELATED AND NOISE INDUCED HEARING LOSS
#214Method and apparatus for imaging target components in a biological sample using permanent magnets
#215Method and apparatus for imaging target components in a biological sample using permanent magnets
#216Method of analyzing lymphocytes
#217Methods for the Diagnosis and Prognosis of Graft Versus Host Disease By Measurement of Peripheral Cd3+Cd4+Cd8Beta+ Cells
#218Cd4+ Cd25+ T-cells activated to a specific antigen
#219Env polypeptide complexes and methods of use
#220Method for preventing HIV-1 infection of CD4 cells
#221Methods for Treating Hiv by Inhibiting Cd4 Down-Modulation
#222CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion
#223CD127 expression inversely correlates with FoxP3 and suppressive function of CD4Tregs
#224Methods To Identify, Prepare, And Use Naive T Cell Recent Thymic Emigrants
#225Simultaneous assay of target and target-drug binding
#226Method for determining the immune status of a subject
#227Nanofraction immune modulators, preparations and compositions including the same, and associated methods
#228Quick Test for the Diagnosis of Alzheimer's Disease
#229Assay implementation in a microfluidic format
#230HUMAN IMMUNODEFICIENCY VIRUS ENTRY INHIBITOR ASSAY
#231Hematopoietic cell phenotyping using free circulating cellular markers
#232Methods for predicting development of auto-immune diseases and treatment of same
#233Cd4+ human papillomavirus (hpv) epitopes
#234Methods for distinguishing type-1 from type-2 diabetes
#235Method of diagnosing osteolysis
#236Method for preventing HIV-1 infection of CD4+ cells
#237Simultaneous assay of target and target-drug binding
#238Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations
#239Cell-based method and assay for measuring the infectivity and drug sensitivity of immunodeficiency virus
#240Three-color reagent for measurement of CD4 positive lymphocytes by flow cytometry